Insiders / Stengone Carmine N. / Activity
Activity — Stengone Carmine N.
11 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Feb 11, 2026 | Exercise | CTNM Contineum Therapeutics, Inc. Class A Common Stock | $504 | +400 +2.67% | 15,354 0.04% of shares | low |
| Feb 25, 2026 | Exercise | CTNM Contineum Therapeutics, Inc. Class A Common Stock | $3.4K | +3K +18.06% | 17,654 0.05% of shares | low |
| Feb 24, 2026 | Exercise | CTNM Contineum Therapeutics, Inc. Class A Common Stock | $5.5K | +4K +29.42% | 19,354 0.05% of shares | low |
| Feb 11, 2026 | Sell | CTNM Contineum Therapeutics, Inc. Class A Common Stock | $6.4K | -400 -2.61% | 14,954 0.04% of shares | low |
| Feb 25, 2026 | Sell | CTNM Contineum Therapeutics, Inc. Class A Common Stock | $43.2K | -3K -15.29% | 14,954 0.04% of shares | low |
| Feb 24, 2026 | Sell | CTNM Contineum Therapeutics, Inc. Class A Common Stock | $70.5K | -4K -22.73% | 14,954 0.04% of shares | low |
| Jun 10, 2026 | Grant | KPRX Kiora Pharmaceuticals, Inc. Stock Option (right to buy) | — | +25K | 25,000 0.57% of shares | low |
| Feb 25, 2026 | Exercise | CTNM Contineum Therapeutics, Inc. Stock Option (right to buy) | — | -3K -2.18% | 120,917 0.32% of shares | low |
| Feb 24, 2026 | Exercise | CTNM Contineum Therapeutics, Inc. Stock Option (right to buy) | — | -4K -3.44% | 123,617 0.33% of shares | low |
| Feb 11, 2026 | Exercise | CTNM Contineum Therapeutics, Inc. Stock Option (right to buy) | — | -400 -0.31% | 128,017 0.34% of shares | low |
| Jan 30, 2026 | Grant | CTNM Contineum Therapeutics, Inc. Stock Option (right to buy) | — | +445K | 445,000 1.18% of shares | low |